Evoke Pharma Inc (EVOK)
0.4435
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 10:28
Evoke Pharma Debt to Equity Ratio: -1.938 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | -1.938 |
September 30, 2023 | -5.722 |
June 30, 2023 | 9.287 |
March 31, 2023 | 2.352 |
December 31, 2022 | 1.224 |
September 30, 2022 | 0.9037 |
June 30, 2022 | 0.6953 |
Date | Value |
---|---|
March 31, 2022 | 2.585 |
December 31, 2021 | 1.406 |
September 30, 2021 | 1.048 |
June 30, 2021 | 0.8381 |
March 31, 2021 | 0.6401 |
December 31, 2020 | -1.588 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-5.722
Minimum
Sep 2023
9.287
Maximum
Jun 2023
0.9024
Average
0.9037
Median
Sep 2022
Debt to Equity Ratio Benchmarks
Eton Pharmaceuticals Inc | 0.3476 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 7.068M |
Total Liabilities (Quarterly) | 9.648M |
Shareholders Equity (Quarterly) | -2.580M |
Current Ratio | 2.249 |